KERRY GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.4 EUR | -0.06% |
|
+0.44% | +0.94% |
| Apr. 02 | Bernstein starts AstraZeneca at 'outperform' | AN |
| Feb. 22 | Transcript : Kerry Group plc Presents at 2024 Consumer Analyst Group of New York Conference, Feb-22-2024 10:00 AM |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +0.94% | 14.73B | A- | ||
| -2.25% | 95.92B | C+ | ||
| +3.76% | 46.89B | C+ | ||
| +1.06% | 40.99B | B- | ||
| +9.58% | 40.43B | B- | ||
| +0.38% | 38.42B | B- | ||
| -15.54% | 30.89B | B- | ||
| -3.45% | 28.96B | A | ||
| +13.48% | 25.11B | A- | ||
| -10.87% | 22.3B | A |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- KRZ Stock
- Ratings Kerry Group plc
